{"transactions":[{"id":4622744,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":35992,"kind":"person","name":"Lynch Ryan","position":1,"cik":"0001709271","reported_name":"Lynch Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Ordinary Shares","published_at":"2026-09-18T20:03:34.000Z","date":"2026-09-16","kind":"sale","planned":true,"acquired":false,"shares":240,"price":17.9,"value":4296.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the settlement of restricted stock units granted to the Reporting Person on December 15, 2025. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 instruction adopted by the Reporting Person on February 25, 2026, solely with the intent to cover taxes in connection with the vesting of the restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.10 to $19.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":13631,"source":{"system":"sec-edgar","filing":"0001628280-26-062709","document":"wk-form4_1789761811.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709271/000162828026062709/wk-form4_1789761811.xml","form_type":"4"}},{"id":729165,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":35992,"kind":"person","name":"Lynch Ryan","position":1,"cik":"0001709271","reported_name":"Lynch Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Ordinary Shares","published_at":"2026-06-23T20:04:56.000Z","date":"2026-06-22","kind":"sale","planned":true,"acquired":false,"shares":465,"price":17.99,"value":8365.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the settlement of restricted stock units granted to the Reporting Person on December 15, 2025. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 instruction adopted by the Reporting Person on February 25, 2026, solely with the intent to cover taxes in connection with the vesting of the restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.88 to $18.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":13871,"source":{"system":"sec-edgar","filing":"0001628280-26-044893","document":"wk-form4_1782245092.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709271/000162828026044893/wk-form4_1782245092.xml","form_type":"4"}},{"id":965082,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":35992,"kind":"person","name":"Lynch Ryan","position":1,"cik":"0001709271","reported_name":"Lynch Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-17T21:38:39.000Z","date":"2025-12-15","kind":"grant","planned":false,"acquired":true,"shares":33512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This Option represents a right to purchase shares of the Issuer's Ordinary Shares and vests with respect to 1/48th of the Option on each monthly anniversary of December 15, 2025, subject to the Reporting Person remaining continuously employed by or providing services to the Issuer or its subsidiaries from December 15, 2025 through each such vesting date."}],"balance_after":33512,"derivative":{"exercise_price":13.21,"expiration_date":"2035-12-15","underlying":"Ordinary Shares","underlying_shares":33512},"source":{"system":"sec-edgar","filing":"0001628280-25-057671","document":"wk-form4_1766007516.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1709271/000162828025057671/wk-form4_1766007516.xml","form_type":"4"}},{"id":965081,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":35992,"kind":"person","name":"Lynch Ryan","position":1,"cik":"0001709271","reported_name":"Lynch Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Ordinary Shares","published_at":"2025-12-17T21:38:39.000Z","date":"2025-12-15","kind":"grant","planned":false,"acquired":true,"shares":4000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Ordinary Shares. The RSUs shall vest in approximately equal three-month installments through the four-year anniversary of December 15, 2025,  subject to the Reporting Person remaining continuously employed by or providing services to the Issuer or its subsidiaries from December 15, 2025 through each such vesting date."}],"balance_after":12378,"source":{"system":"sec-edgar","filing":"0001628280-25-057671","document":"wk-form4_1766007516.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709271/000162828025057671/wk-form4_1766007516.xml","form_type":"4"}},{"id":965080,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":35992,"kind":"person","name":"Lynch Ryan","position":1,"cik":"0001709271","reported_name":"Lynch Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Ordinary Shares","published_at":"2025-12-17T21:38:39.000Z","date":"2025-12-15","kind":"grant","planned":false,"acquired":true,"shares":8378,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Ordinary Shares. The RSUs shall vest in approximately equal three-month installments through the four-year anniversary of December 15, 2025,  subject to the Reporting Person remaining continuously employed by or providing services to the Issuer or its subsidiaries from December 15, 2025 through each such vesting date."}],"balance_after":8378,"source":{"system":"sec-edgar","filing":"0001628280-25-057671","document":"wk-form4_1766007516.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709271/000162828025057671/wk-form4_1766007516.xml","form_type":"4"}},{"id":3434616,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":35992,"kind":"person","name":"Lynch Ryan","position":1,"cik":"0001709271","reported_name":"Lynch Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PAO"}}],"security":"Common Stock","published_at":"2019-08-19T10:20:15.000Z","date":"2019-08-15","kind":"grant","acquired":true,"shares":14063,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Common Stock of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"35% of the RSUs granted to Mr. Lynch will vest on August 15, 2020, and the remaining 65% of the RSUs will vest on August 15, 2021. The number above represents the maximum number of shares that may be delivered pursuant to the award."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."}],"balance_after":18059,"source":{"system":"sec-edgar","filing":"0001209191-19-046446","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709271/000120919119046446/doc4.xml","form_type":"4"}},{"id":3569000,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":35992,"kind":"person","name":"Lynch Ryan","position":1,"cik":"0001709271","reported_name":"Lynch Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PAO"}}],"security":"Common Stock","published_at":"2019-04-02T20:16:01.000Z","date":"2019-03-31","kind":"tax_withholding","acquired":false,"shares":1043,"price":12.07,"value":12589.01,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction represents withholding of shares to satisfy tax withholding obligations upon the vesting of restricted stock units."}],"balance_after":3996,"source":{"system":"sec-edgar","filing":"0001209191-19-022410","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709271/000120919119022410/doc4.xml","form_type":"4"}},{"id":3700452,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":35992,"kind":"person","name":"Lynch Ryan","position":1,"cik":"0001709271","reported_name":"Lynch Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PAO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-01-08T21:10:00.000Z","date":"2019-01-04","kind":"grant","acquired":true,"shares":6100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in sixteen equal quarterly installments beginning on April 4, 2019."}],"balance_after":6100,"derivative":{"exercise_price":13.93,"expiration_date":"2029-01-03","underlying":"Common Stock","underlying_shares":6100},"source":{"system":"sec-edgar","filing":"0001209191-19-002762","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709271/000120919119002762/doc4.xml","form_type":"4"}},{"id":3973481,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":35992,"kind":"person","name":"Lynch Ryan","position":1,"cik":"0001709271","reported_name":"Lynch Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PAO"}}],"security":"Common Stock","published_at":"2018-04-03T20:22:55.000Z","date":"2018-03-31","kind":"tax_withholding","acquired":false,"shares":961,"price":22.9,"value":22006.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction represents withholding of shares to satisfy tax withholding obligations upon the vesting of restricted stock units."}],"balance_after":5039,"source":{"system":"sec-edgar","filing":"0001209191-18-022950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709271/000120919118022950/doc4.xml","form_type":"4"}},{"id":4104350,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":35992,"kind":"person","name":"Lynch Ryan","position":1,"cik":"0001709271","reported_name":"Lynch Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PAO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-01-08T23:30:22.000Z","date":"2018-01-04","kind":"grant","acquired":true,"shares":4950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in sixteen equal quarterly installments beginning on April 4, 2018."}],"balance_after":4950,"derivative":{"exercise_price":27.59,"expiration_date":"2028-01-03","underlying":"Common Stock","underlying_shares":4950},"source":{"system":"sec-edgar","filing":"0001209191-18-002786","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709271/000120919118002786/doc4.xml","form_type":"4"}},{"id":4207310,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":35992,"kind":"person","name":"Lynch Ryan","position":1,"cik":"0001709271","reported_name":"Lynch Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PFO, PAO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-09-18T20:40:55.000Z","date":"2017-09-14","kind":"exercise","acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty five percent (25%) of the shares subject to this option vested on June 12, 2015, and the option vested and will continue to vest in equal quarterly installments thereafter, until June 12, 2018, at which time this option will be fully vested."}],"balance_after":3200,"derivative":{"exercise_price":9.46,"expiration_date":"2024-06-11","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001209191-17-053165","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1709271/000120919117053165/doc4.xml","form_type":"4"}},{"id":4207309,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":35992,"kind":"person","name":"Lynch Ryan","position":1,"cik":"0001709271","reported_name":"Lynch Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PFO, PAO"}}],"security":"Common Stock","published_at":"2017-09-18T20:40:55.000Z","date":"2017-09-14","kind":"sale","acquired":false,"shares":3500,"price":14.51,"value":50785.0,"ownership":{"direct":true},"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001209191-17-053165","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709271/000120919117053165/doc4.xml","form_type":"4"}},{"id":4207308,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":35992,"kind":"person","name":"Lynch Ryan","position":1,"cik":"0001709271","reported_name":"Lynch Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PFO, PAO"}}],"security":"Common Stock","published_at":"2017-09-18T20:40:55.000Z","date":"2017-09-14","kind":"exercise","acquired":true,"shares":3500,"price":9.46,"value":33110.0,"ownership":{"direct":true},"balance_after":9500,"source":{"system":"sec-edgar","filing":"0001209191-17-053165","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709271/000120919117053165/doc4.xml","form_type":"4"}},{"id":4260010,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":35992,"kind":"person","name":"Lynch Ryan","position":1,"cik":"0001709271","reported_name":"Lynch Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PFO, PAO"}}],"security":"Common Stock","published_at":"2017-07-10T11:12:36.000Z","date":"2017-07-06","kind":"grant","acquired":true,"shares":6000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Common Stock of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"These shares of Common Stock are issuable pursuant to a grant of RSUs that vest  as follows: (i) 50% on March 31, 2018 and (ii) 50% on March 31, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001209191-17-044475","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709271/000120919117044475/doc4.xml","form_type":"4"}}]}